Position in TMO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$76,018,710
-$133,712,225 QoQ
Shares Held
151,625
-64.5% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#230
of 2,617 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OMERS ADMINISTRATION Corp holds $118,030,675 across 12 Diagnostics & Research names. TMO ranks #1 (64.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
151,625 | $76,018,710 | |
| 2 | DHR |
Danaher Corp /De/
|
61,949 | $11,800,045 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
13,373 | $7,040,082 | |
| 4 | ILMN |
Illumina, Inc.
|
28,992 | $5,097,663 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
3,573 | $4,564,543 | |
| 6 | NTRA |
Natera, Inc.
|
12,821 | $3,480,260 | |
| 7 | A |
Agilent Technologies, Inc.
|
16,716 | $2,220,386 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
4,030 | $2,134,247 |
All Filings in TMO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,018,710 | 151,625 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $209,730,935 | 426,690 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $244,866,878 | 422,585 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $232,489,486 | 479,340 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $194,273,726 | 479,144 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $190,348,918 | 382,534 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $199,647,106 | 383,767 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $236,880,762 | 382,949 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $211,715,497 | 382,849 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $294,175,373 | 506,143 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $268,655,642 | 506,143 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $229,879,130 | 454,154 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $236,954,849 | 454,154 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $261,760,740 | 454,154 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $250,098,066 | 454,154 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $230,342,367 | 454,154 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $246,732,785 | 454,154 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $268,246,060 | 454,154 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $286,815,782 | 429,854 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $231,380,651 | 404,986 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $96,243,239 | 210,884 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $54,856,773 | 117,774 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||